This study aimed to evaluate the validity, reliability, and diagnostic accuracy of the Turkish version of MoCA-B in distinguishing healthy controls, mild cognitive impairment (MCI), and dementia patients within a low-education population.
Who can participate
Age range
50 Years – 100 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age 50-100 years
* Presented with memory complaints and were evaluated in the Neurology/Dementia outpatient clinics of Antalya Training and Research Hospital (Jan 2024-Nov 2025)
* Low educational attainment (illiterate to primary school level)
* Provided informed consent
Exclusion Criteria:
* Active psychiatric disorders / active psychopathology
* Intracranial mass lesions
* Secondary causes of dementia
* Severe medical conditions affecting cognition
* History of traumatic brain injury
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This study was testing a cognitive screening tool called the MoCA-B specifically for people with low educational levels — does my own education level affect which cognitive assessment tool my doctor currently uses to evaluate me, and could this type of test be more appropriate for me?
2Since this trial has already been completed and was focused on validating a diagnostic screening tool rather than testing a treatment, are the results available and could they change how my doctor screens me for mild cognitive impairment or dementia?
3The study was establishing cut-off points for the MoCA-B in Turkish-speaking populations — if I or my family member speaks Turkish or comes from a similar background with limited formal education, should my doctor be using a culturally and educationally adjusted version of a cognitive test rather than a standard one?
4Because this was a diagnostic validation study and not a treatment trial, what does my doctor recommend as the next step if a cognitive screening test — like the one studied here — suggests I might have mild cognitive impairment or early dementia?
5This study focused on people with low educational levels, which can affect how cognitive test scores are interpreted — how does my own educational background factor into the way my doctor interprets my current cognitive assessments?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
MoCA-B cut off points
Timeframe: at baseline and after 4 weeks (test-retest)